lg 100268 has been researched along with Coronary Artery Disease in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laffitte, BA | 1 |
| Joseph, SB | 1 |
| Chen, M | 1 |
| Castrillo, A | 1 |
| Repa, J | 1 |
| Wilpitz, D | 1 |
| Mangelsdorf, D | 1 |
| Tontonoz, P | 1 |
1 other study available for lg 100268 and Coronary Artery Disease
| Article | Year |
|---|---|
The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Arteriosclerosis; Benzoates; Benzylamines; Car | 2003 |